Healthcare costs in the United States are incredibly high, we all (hopefully) are aware of that fact. Yet, seeing the actual numbers on paper is truly staggering. According to a recent Forbes article,the latest costs come in at over $900 billion. The article cited that aging and population growth were a great driver in this number skyrocketing. However, the main cause was just plain higher charges and patient care becoming more expensive.
It seems like a no-brainer that if the medical community and insurance companies worked together those costs could be brought down. That isn’t likely to happen. In fact, the article even cited that it is the actual pricing structure of getting health care that is directly responsible for the nearly unbelievable cost of healthcare in the United States.
So, we are left with the healthcare system and the insurance companies at odds, and the loser is the American people. It seems that in order to bring about change we will need a huge disruptor in the healthcare field.
One such disruptor is Tempus, a company that merges healthcare and technology in order to build the largest library of clinical and molecular data that the world has ever seen. In addition to that library, they are using the latest technology to build a universally accessible operations system so that the collected data is immediately accessible to physicians across the globe. Tempus will specifically focus on cancer patients and will utilize a machine learning system that will enable physicians to create highly specialized cancer care treatment plans for each individual patient based on collected big data.
Tempus is the brainchild of Eric Lefkofsky. He is a leader in the technology sector in America and is based out of Chicago. Lefkofsky founded Tempus after noticing that cancer data was being collected for each patient but that there was no centralized system that housed that data and made it available to other physicians.
Outside of the technology sector, Lefkofsky has the Lefkofsky Family Foundation. One of the major goals of the Foundation is to propel highly innovative medical research. Through the launch of Tempus, Lefkofsky is bringing the innovation to life.